1014 Pharmacy and therapeutic committee have to develop and revise the

1014 pharmacy and therapeutic committee have to

This preview shows page 2 - 3 out of 3 pages.

1014). Pharmacy and therapeutic committee have to develop and revise the formulary reviews and evaluating new medications for formulary consideration to provide cost-effective, clinically safe, and effective therapy (Arcangelo et al., 2017, p. 1014). Eighty three percentage of nurse practitioners believed that their choices of drug were influenced by availability of drug samples that was promoted from a pharmacy company instead of clinical reason (Crigger and Holcomb, 2008). Prescriber should put patient and family member in the center of the treatment plan. Consideration of patient’s autonomy and empowerment on decision making are important for thepatient to continue to take medication for the effective therapy. Patients often hesitate to pay the high copayment for their medications (Arcangelo, et al., 2017, p. 2017). Provider should activelyinvolve a patient and family member to access for the medication.StrategiesAccording to Crigger and Holcomb (2008), inappropriate prescribing occurs when providers have lack of knowledge or allow external social or psychological pressures to make treatment decision on patient. A prescriber should have good knowledge about the drugs and their pharmacokinetics. Thus, a patient can get the right therapeutic medication to their physical condition. Prescriber should have good assessment skills on patients not only the physical
Background image
Image of page 3

You've reached the end of your free preview.

Want to read all 3 pages?

  • Summer '15
  • Arcangelo, left coronary artery, American nurse association

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture